CCL2 and pulmonary arterial hypertension: PAH progression in SuHxNx rats was associated at week 9 with significantly elevated expression of eight key markers, including Il6 and Ccl2, and in each case therapeutic treatment with RAP-011—but not vehicle or sildenafil—fully normalized their mRNA levels (Fig. 2A).